Back to search

Article

Impaired Immunogenicity to COVID-19 Vaccines in Autoimmune Systemic Diseases - High Prevalence of Non-Response in Different Patients’ Subgroups

2021-10-14

Abstract excerpt

Background: Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19 vaccines . Our prospective observational multicenter study aimed to evaluate the seroconversion after the vaccination cycle and at 6-12-month follow-up, as well the safety and efficacy of vaccines in preventing COVID-19.<br><br>Methods: The study included 478 unselected ASD patients (mean age 59±15 years), namely 101 rhe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0896a10b-92c8-5ec1-aee8-8127452ee426
DOI
10.2139/ssrn.3942651
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impaired Immunogenicity to COVID-19 Vaccines in Autoimmune Systemic Diseases - High Prevalence of Non-Response in Different Patients’ SubgroupsDOI 10.2139/ssrn.3942651
Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patientsSemantic proximity
COVID-19 vaccines and autoimmune disorders: A scoping review protocolSemantic proximity
Anti-SARS-CoV-2 immunogenicity decay and incident cases six months after Sinovac-CoronaVac inactivated vaccine in autoimmune rheumatic diseases patients: phase 4 prospective trialSemantic proximity
Patients treated with anti-CD20 therapy can mount robust T cell responses to mRNA-based COVID-19 vaccinesSemantic proximity
Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this conditionSemantic proximity
The Impact of COVID-19 Vaccination on Autoimmune Disorders: A Descriptive AnalysisSemantic proximity
Predominance of Distinct Autoantibodies in Response to SARS-CoV-2 InfectionSemantic proximity
Humoral Immune Response Following SARS-CoV-2 mRNA Vaccination and Infection in Pediatric-Onset Multiple SclerosisSemantic proximity
Newly Diagnosed Systemic Lupus Erythematosus after Sars-Cov-2 Vaccination: Coincidental or Relevant?Semantic proximity
Recent developments in the immunopathology of COVID-19Semantic proximity
Rapid Progressive Systemic Sclerosis Following mRNA COVID-19 VaccinationSemantic proximity
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20 treated patients with multiple sclerosis after three or four COVID-19 vaccinationsSemantic proximity
Select a neighboring publication to make it the new centre.